Skip to main content
Charles Raison, MD, Psychiatry, Madison, WI

CharlesLRaisonMD

Psychiatry Madison, WI

Integrative Psychiatry

Barry and Janet Lang Associate Professor of Integrative Mental Health

Dr. Raison is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Raison's full profile

Already have an account?

  • Office

    600 Highland Ave
    Madison, WI 53792
    Phone+1 608-263-6100
    Fax+1 608-263-7263

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Psychiatry, 1991 - 1995
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 1991

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1993 - Present
  • WI State Medical License
    WI State Medical License 2015 - 2025
  • AZ State Medical License
    AZ State Medical License 2012 - 2016
  • GA State Medical License
    GA State Medical License 1999 - 2013
  • American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

  • Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Approaching the Great Western Divide 
    University of Arizona College of Medicine at the Arizona Health Sciences Center, Sequoia National Pa - 7/23/2013
  • 25th Annual U.S. Psychiatric and Mental Health Congress 
    North American Center for Continuing Medical Education, LLC / CME LLC, San Diego, California - 11/8/2012

Other

Press Mentions

  • What Experts Say About Taking Psilocybin as an Alternative Treatment for Depression
    What Experts Say About Taking Psilocybin as an Alternative Treatment for DepressionOctober 22nd, 2024
  • Millions Could Qualify for Psilocybin Therapy: Study Predicts Massive Demand if FDA Approves Depression Therapy
    Millions Could Qualify for Psilocybin Therapy: Study Predicts Massive Demand if FDA Approves Depression TherapySeptember 16th, 2024
  • Researchers Identify an Unexpected Cause Behind Depression
    Researchers Identify an Unexpected Cause Behind DepressionFebruary 26th, 2023
  • Join now to see all

Grant Support

  • Inflammation, Stress, And Social Behavior: Using Ecological Assessments And ModelNational Center For Complementary &Alternative Medicine2011
  • Mechanisms Of MeditationNational Center For Complementary &Alternative Medicine2009–2011
  • Neurobiological And Behavioral Effects Of Cytokine Antagonism In Major DepressionNational Institute Of Mental Health2008–2009
  • Cytokine-Crh Interactions In Ifn-Alfa-Induced DepressionNational Institute Of Mental Health2005–2009
  • Compassion Meditation As A Strategy For Reducing Depression Symptoms ANS PhysiolNational Center For Research Resources2007
  • Phenotyping Immune-Based DepressionNational Center For Research Resources2004–2007
  • Compassion MeditationNational Center For Research Resources2006
  • Glucocorticoid Resistance In Immune-Based DepressionNational Institute Of Mental Health2002–2006